Main container

Una sperimentazione in aperto (open label) di fase I/IIa che ripropone la carbamazepina (CBZ) per il trattamento di displasia scheletrica nei bambini

Title
Una sperimentazione in aperto (open label) di fase I/IIa che ripropone la carbamazepina (CBZ) per il trattamento di displasia scheletrica nei bambini
Code
MCDS-Therapy
Type
Sperimentale
Start Year
2022
Status
Terminato

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in

Clinical Trial
A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors
Read more
Clinical Trial
Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors
Read more